Authors: BOUMA G POOL MO SCHARENBERG JGM KOLKMAN JJ VONBLOMBERG BME SCHEPER RJ MEUWISSEN SGM PENA AS

Citation: G. Bouma et al., DIFFERENCES IN THE INTRINSIC CAPACITY OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS TO PRODUCE TUMOR-NECROSIS-FACTOR-ALPHA AND TUMOR-NECROSIS-FACTOR-BETA IN PATIENTS WITH INFLAMMATORY-BOWEL-DISEASE AND HEALTHY CONTROLS, Scandinavian journal of gastroenterology, 30(11), 1995, pp. 1095-1100

Authors: SCHARENBERG JGM STAM AGM VONBLOMBERG BME ROEST GJ PALMER PA FRANKS CR MEIJER CJLM SCHEPER RJ

Citation: Jgm. Scharenberg et al., THE DEVELOPMENT OF ANTI-INTERLEUKIN-2 (IL-2) ANTIBODIES IN CANCER-PATIENTS TREATED WITH RECOMBINANT IL-2, European journal of cancer, 30A(12), 1994, pp. 1804-1809

Authors: PALMER PA SCHARENBERG JGM VONBLOMBERG BME STAM AGM MEIJER CJLM ROEST GJ FRANKS CR SCHEPER RJ

Citation: Pa. Palmer et al., PERSISTENT AUGMENTATION OF NATURAL-KILLER-MEDIATED AND T-CELL-MEDIATED CYTOTOXICITY IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS PULSED IN-VITRO WITH HIGH-DOSE RECOMBINANT INTERLEUKIN-2 PRIOR TO CULTURING WITH A LOW MAINTENANCE DOSE, Cancer immunology and immunotherapy, 39(1), 1994, pp. 34-40

Authors: VLASVELD LT HEKMAN A VYTHDREESE FA RANKIN EM SCHARENBERG JGM VOORDOUW AC SEIN JJ DELLEMIJN TAM RODENHUIS S MELIEF CJM

Citation: Lt. Vlasveld et al., A PHASE-I STUDY OF PROLONGED CONTINUOUS-INFUSION OF LOW-DOSE RECOMBINANT INTERLEUKIN-2 IN MELANOMA AND RENAL-CELL CANCER .2. IMMUNOLOGICAL ASPECTS, British Journal of Cancer, 68(3), 1993, pp. 559-567